VIRTUAL EXPERIENCE
Home
Agenda
2021 Agenda
2020 Agenda
2019 Agenda
2018 Agenda
Speakers
2021 Speakers
2020 Speakers
2019 Speakers
2018 Speakers
Attendees
Partners
Commercial Partners 2021
Commercial Partners 2020
Commercial Partners 2019
Commercial Partners 2018
Sponsorship Opportunities
Host a Webinar
Media Partners
Note to exhibitors
Summit Details
Delegate Registration
2020 Attendees
Latest news
Content Zone
Contact Us
Book Now
Biopharmaceutics Risk Assessment During Formulation and Clinical Development
3/12/2018
09:50 - 10:25
Role of in vitro, in silico and in vivo tools in formulation develop: Case Studies
Combination of preclinical data with modelling and simulation to inform clinical formulation selection
Driving Quality by Design via Biopharmaceutics Risk Assessment: Case Studies
Filippos Kesisoglou
, Senior Principal Scientist, Biopharmaceutics and Pharmaceutical Sciences
, MSD
Back to programme
Filippos Kesisoglou
Senior Principal Scientist, Biopharmaceutics and Pharmaceutical Sciences
MSD